This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
The incidence of prostate cancer is increasing and it is the main cause of male death. We show new sights of CDK2 in the inhibition of prostate cancer.
This page is a summary of: Identification of CDK2 as a novel target in treatment of prostate cancer, Future Oncology, April 2018, Future Medicine,
DOI: 10.2217/fon-2017-0561.
You can read the full text:
The following have contributed to this page
F1000Research
This study uses systematic literature reviewing techniques to chart the impacts of pandemic school closure considered in past studies.
British Journal of Cancer
We have discovered why some prostate cancers are more aggressive, spread to different parts of the body, and ultimately cause death. Recently we developed a test to distinguish aggressive prostate...
Anti-Cancer Agents in Medicinal Chemistry
This work supports the evidence that cedrelone is able to kill triple negative breast tumor cancer (TNBC) dells and also to interfere with adhesion, migration and invasion of these cells.
